SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
26 hedge funds and large institutions have $81.9M invested in Sierra Oncology, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
26
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$425K | |
| 2 | +$421K | |
| 3 | +$118K | |
| 4 |
Renaissance Technologies
New York
|
+$115K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$70.2K |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$223K | |
| 3 | -$151K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$53K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$30K |